These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 23667909)

  • 1. Mast cells limit extracellular levels of IL-13 via a serglycin proteoglycan-serine protease axis.
    Waern I; Karlsson I; Thorpe M; Schlenner SM; Feyerabend TB; Rodewald HR; Åbrink M; Hellman L; Pejler G; Wernersson S
    Biol Chem; 2012 Dec; 393(12):1555-67. PubMed ID: 23667909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-6 and IL-17A degradation by mast cells is mediated by a serglycin:serine protease axis.
    Waern I; Karlsson I; Pejler G; Wernersson S
    Immun Inflamm Dis; 2016 Mar; 4(1):70-9. PubMed ID: 27042303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protease-proteoglycan complexes of mouse and human mast cells and importance of their beta-tryptase-heparin complexes in inflammation and innate immunity.
    Stevens RL; Adachi R
    Immunol Rev; 2007 Jun; 217():155-67. PubMed ID: 17498058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mast cell-dependent activation of pro matrix metalloprotease 2: A role for serglycin proteoglycan-dependent mast cell proteases.
    Lundequist A; Abrink M; Pejler G
    Biol Chem; 2006; 387(10-11):1513-9. PubMed ID: 17081126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serglycin proteoglycan is required for secretory granule integrity in mucosal mast cells.
    Braga T; Grujic M; Lukinius A; Hellman L; Abrink M; Pejler G
    Biochem J; 2007 Apr; 403(1):49-57. PubMed ID: 17147513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distorted secretory granule composition in mast cells with multiple protease deficiency.
    Grujic M; Calounova G; Eriksson I; Feyerabend T; Rodewald HR; Tchougounova E; Kjellén L; Pejler G
    J Immunol; 2013 Oct; 191(7):3931-8. PubMed ID: 23975861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serglycin-independent release of active mast cell proteases in response to Toxoplasma gondii infection.
    Sawesi O; Spillmann D; Lundén A; Wernersson S; Åbrink M
    J Biol Chem; 2010 Dec; 285(49):38005-13. PubMed ID: 20864536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of histochemical identity in mast cells lacking carboxypeptidase A.
    Feyerabend TB; Hausser H; Tietz A; Blum C; Hellman L; Straus AH; Takahashi HK; Morgan ES; Dvorak AM; Fehling HJ; Rodewald HR
    Mol Cell Biol; 2005 Jul; 25(14):6199-210. PubMed ID: 15988029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serglycin: the master of the mast cell.
    Rönnberg E; Pejler G
    Methods Mol Biol; 2012; 836():201-17. PubMed ID: 22252637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteolytic histone modification by mast cell tryptase, a serglycin proteoglycan-dependent secretory granule protease.
    Melo FR; Vita F; Berent-Maoz B; Levi-Schaffer F; Zabucchi G; Pejler G
    J Biol Chem; 2014 Mar; 289(11):7682-90. PubMed ID: 24478313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A role for serglycin proteoglycan in granular retention and processing of mast cell secretory granule components.
    Henningsson F; Hergeth S; Cortelius R; Abrink M; Pejler G
    FEBS J; 2006 Nov; 273(21):4901-12. PubMed ID: 17010166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Degradation of Monocyte Chemoattractant Protein-1 by Tryptase Co-Released in Immunoglobulin E-Dependent Activation of Primary Human Cultured Mast Cells.
    Tam IYS; Ng CW; Lau HYA; Tam SY
    Int Arch Allergy Immunol; 2018; 177(3):199-206. PubMed ID: 30021208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mast cell differentiation and activation is closely linked to expression of genes coding for the serglycin proteoglycan core protein and a distinct set of chondroitin sulfate and heparin sulfotransferases.
    Duelli A; Rönnberg E; Waern I; Ringvall M; Kolset SO; Pejler G
    J Immunol; 2009 Dec; 183(11):7073-83. PubMed ID: 19915053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serotonin and histamine storage in mast cell secretory granules is dependent on serglycin proteoglycan.
    Ringvall M; Rönnberg E; Wernersson S; Duelli A; Henningsson F; Abrink M; García-Faroldi G; Fajardo I; Pejler G
    J Allergy Clin Immunol; 2008 Apr; 121(4):1020-6. PubMed ID: 18234316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered storage of proteases in mast cells from mice lacking heparin: a possible role for heparin in carboxypeptidase A processing.
    Henningsson F; Ledin J; Lunderius C; Wilén M; Hellman L; Pejler G
    Biol Chem; 2002 May; 383(5):793-801. PubMed ID: 12108544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A role for serglycin proteoglycan in mast cell apoptosis induced by a secretory granule-mediated pathway.
    Melo FR; Waern I; Rönnberg E; Åbrink M; Lee DM; Schlenner SM; Feyerabend TB; Rodewald HR; Turk B; Wernersson S; Pejler G
    J Biol Chem; 2011 Feb; 286(7):5423-33. PubMed ID: 21123167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mast cell chymase degrades the alarmins heat shock protein 70, biglycan, HMGB1, and interleukin-33 (IL-33) and limits danger-induced inflammation.
    Roy A; Ganesh G; Sippola H; Bolin S; Sawesi O; Dagälv A; Schlenner SM; Feyerabend T; Rodewald HR; Kjellén L; Hellman L; Åbrink M
    J Biol Chem; 2014 Jan; 289(1):237-50. PubMed ID: 24257755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Packaging of proteases and proteoglycans in the granules of mast cells and other hematopoietic cells. A cluster of histidines on mouse mast cell protease 7 regulates its binding to heparin serglycin proteoglycans.
    Matsumoto R; Sali A; Ghildyal N; Karplus M; Stevens RL
    J Biol Chem; 1995 Aug; 270(33):19524-31. PubMed ID: 7642636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction with dithiothreitol causes serglycin-specific defects in secretory granule integrity of bone marrow derived mast cells.
    Braga T; Ringvall M; Tveit H; Abrink M; Pejler G
    Mol Immunol; 2009 Jan; 46(3):422-8. PubMed ID: 19059647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chymase bound to heparin is resistant to its natural inhibitors and capable of proteolyzing high density lipoproteins in aortic intimal fluid.
    Lindstedt L; Lee M; Kovanen PT
    Atherosclerosis; 2001 Mar; 155(1):87-97. PubMed ID: 11223430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.